SCHW vs SLS · P/E 19, rev $13.55B vs $1.62B cap
Charles Schwab Corp (SCHW) versus Sellas Life Sciences Group Inc (SLS) — a side-by-side from cached financials, not a winner call.
Charles Schwab Corp (SCHW) is a capital markets company listed on NYSE. It is led by Walt Bettinger.
Sellas Life Sciences Group Inc (SLS) is a biotechnology company listed on US.
Latest reported SCHW revenue for 2026-06-30 was $13.55B. Net income was $5.28B. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
Latest reported SLS revenue for 2026-06-30 was $0. Net income was -$18.0M. SLS currently screens at market cap $1.62B.
SCHW currently screens at market cap $164.37B and trailing P/E 18.8. SLS currently screens at market cap $1.62B.
Not investment advice. Open the SCHW and SLS stock pages for the full models.
Not investment advice.